Cover Story
CEOCFO
Interview
Index &
Quotes
CEOCFO
Current Issue
Future
Features
Monthly
Analyst
Industry
Review
Analyst
Interviews
and Reports
Corporate
Financials
Archived
CEOCFO
Interviews
About
CEOCFO
interviews.com
Contact
& Ordering |
Click here to view Analyst
interview with:
Karen
Gilsenan, First Vice President,
Covering: Specialty Chemicals
Merrill Lynch
Sigma-Aldrich - a chemical company
with
unrivaled scientific knowledge and
more products than anyone else
Basic Materials
Chemical Manufacturing
NASD: SIAL
Sigma-Aldrich Corp.
3050 Spruce Street
St. Louis, MO 63103
Phone: 314-771-5765
David Harvey
Chairman and
Chief Executive Officer
Interview conducted by:
Walter Banks
Co-Publisher
CEOCFOinterviews.com
January 2002
Bio of CEO,
David R. Harvey serves as Chairman, President and Chief Executive Officer of
Sigma-Aldrich Corporation, a $1.2 billion global life science company headquartered in St.
Louis, Missouri. Dr. Harvey joined the
company in 1974 as Vice President of European operations. In 1981, he moved to Milwaukee,
Wisconsin becoming President of Aldrich Chemical. He
served as Chief Operating Officer of Sigma-Aldrich Corporation from 1986 until 1999 when
he was named as President and Chief Executive Officer.
In addition to these duties, he also became Chairman of the Board in 2001. Prior to joining the company, he worked from
1965 at Shell International Chemical Company in various international sales and marketing
activities. Dr. Harvey holds a Ph.D. in
Chemistry from Oxford University
About Sigma-Aldrich Corp.
Sigma-Aldrich (NASDAQ:SIAL) is a leading Life Science and High Technology company. Its biochemical and organic chemical products and
kits are used in scientific and genomic research, biotechnology, pharmaceutical
development, the diagnosis of disease and chemical manufacturing. It has customers in life
science companies, university and government institutions, hospitals and in industry.
Sigma-Aldrich operates in 33 countries and has over 6,600 employees providing excellent
service worldwide.
Sigma-Aldrich is committed to the success of its Customers, Employees and
Shareholders through leadership in Life Science, High Technology and
Service.
Sigma-Aldrich offers the research community 200,000 products with 85,000 listed in
its general catalogs and another 115,000 in its rare chemicals library. Through
interaction with customers, Sigma-Aldrich determines what technologies and products they
need to move forward in their research. This close interaction is driving their expanded
R&D program. Many innovative products are in the pipeline to further their leadership
position.
They have five well-known chemical brands. Each one addresses a defined area of
customer needs and has earned a reputation for quality and performance:
Sigma - Biochemicals and Reagents for Life Science Research.
Aldrich - Organics and Inorganics for Chemical Synthesis.
Fluka - Specialty Chemicals and Analytical Reagents for Research.
Supelco - Chromatography Products for Analysis and Purification.
Riedel-de Haen - Laboratory Chemicals and Reagents for Research and Analysis.
Sigma Diagnostics provides reagents and instruments to clinical laboratories,
hospitals and physicians.
Through its family of brands, Sigma-Aldrich offers the widest range of modern
research products, fine chemicals, and diagnostic products and the highest level of
customer commitment. Their combined aim is to deliver quality products, technical
expertise, global availability and convenient purchasing methods.
CEOCFOinterviews: Mr.
Harvey, please give us a brief history of Sigma-Aldrich?
Mr. Harvey: “The
company goes back just over 50 years. It was
started by entrepreneurs here in St. Louis, MO, on the biochemical side and in Milwaukee,
WI on the organic chemical side. For the two companies, as is the case with most
entrepreneurs, the early years were tough going, but by 1975, when they merged, they came
together with total revenues of about $40 million. $10 million of that was on the organic
side, that's the Aldrich part of the business. On its Sigma side, the biochemical side, we
had $30 million, giving us a total of $40 million. Since the amalgamation, the company has
grown to where today it has sales of about 1.2 billion dollars, and is now one of the top
150 chemical companies in the world.”
CEOCFOinterviews: How
long have you been with Sigma-Aldrich?
Mr. Harvey: “I've
been with Sigma-Aldrich since 1974, and in fact I joined the company just before the
merger of Sigma and Aldrich. I joined on the Aldrich side of the business. My initial role
for both Aldrich and Sigma-Aldrich was as Vice President of European Operations. I came to
the United States in 1981, when I became the President of Aldrich Chemical Company. I was
named the Chief Operating Officer of the company in 1983, and became the CEO two years ago
and the Chairman and CEO exactly a year ago. Therefore, I have a long history with the
company going back 27 years.”
CEOCFOinterviews: What
would you say is your most recent and exciting news?
To
receive a complete copy of this interview call:
570-839-0236
|
